119 related articles for article (PubMed ID: 12023424)
1. Prognostic value of platelet derived growth factor alpha receptor expression in grade 2 astrocytomas and oligoastrocytomas.
Ribom D; Andrae J; Frielingsdorf M; Hartman M; Nistér M; Smits A
J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):782-7. PubMed ID: 12023424
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
3. Expression of autocrine motility factor mRNA is a poor prognostic factor in high-grade astrocytoma.
Tanizaki Y; Sato Y; Oka H; Utsuki S; Kondo K; Miyajima Y; Nagashio R; Fujii K
Pathol Int; 2006 Sep; 56(9):510-5. PubMed ID: 16930331
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor receptor alpha (PDGFRα) is overexpressed in NK/T-cell lymphoma and mediates cell survival.
Lu L; Fu X; Li Z; Qiu Y; Li W; Zhou Z; Xue W; Wang Y; Jin M; Zhang M
Biochem Biophys Res Commun; 2018 Oct; 504(2):525-531. PubMed ID: 30201265
[TBL] [Abstract][Full Text] [Related]
5. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of vascular adhesion protein-1 is associated with poor prognosis of astrocytomas.
Kostoro J; Chang SJ; Clark Lai YC; Wu CC; Chai CY; Kwan AL
APMIS; 2016 Jun; 124(6):462-8. PubMed ID: 26935340
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-13 receptor alpha 2 as a marker of poorer prognosis in high-grade astrocytomas.
Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Otsuka Y; Yamaguchi M; Ohnishi H; Ohtaki S; Noshiro S; Ookawa S; Mikami T; Mikuni N; Honmou O
J Neurosurg Sci; 2018 Jun; 62(3):239-244. PubMed ID: 28079349
[TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular characterization of IDH1-mutated diffuse low grade gliomas reveals tumor heterogeneity and absence of EGFR/PDGFRα activation.
Azar S; Leventoux N; Ripoll C; Rigau V; Gozé C; Lorcy F; Bauchet L; Duffau H; Guichet PO; Rothhut B; Hugnot JP
Glia; 2018 Feb; 66(2):239-255. PubMed ID: 29027701
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
Peraud A; Kreth FW; Wiestler OD; Kleihues P; Reulen HJ
Clin Cancer Res; 2002 May; 8(5):1117-24. PubMed ID: 12006527
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of survivin and DNA topoisomerase IIα in diffuse and anaplastic astrocytomas.
Varughese RK; Skjulsvik AJ; Torp SH
Pathol Res Pract; 2017 Apr; 213(4):339-347. PubMed ID: 28214203
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis.
Korkolopoulou P; Patsouris E; Konstantinidou AE; Pavlopoulos PM; Kavantzas N; Boviatsis E; Thymara I; Perdiki M; Thomas-Tsagli E; Angelidakis D; Rologis D; Sakkas D
Neuropathol Appl Neurobiol; 2004 Jun; 30(3):267-78. PubMed ID: 15175080
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis.
Yu JH; Kim JM; Kim JK; Choi SJ; Lee KS; Lee JW; Chang HY; Lee JI
Oncotarget; 2017 Jun; 8(24):39534-39546. PubMed ID: 28465473
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of astrocyte elevated gene-1 in human astrocytomas.
He Z; He M; Wang C; Xu B; Tong L; He J; Sun B; Wei L; Chu M
Int J Clin Exp Pathol; 2014; 7(8):5038-44. PubMed ID: 25197376
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of loss of O6-methylguanine-DNA methyltransferase expression in supratentorial diffuse low-grade astrocytoma.
Nakasu S; Fukami T; Jito J; Matsuda M
Surg Neurol; 2007 Dec; 68(6):603-608. PubMed ID: 17825378
[TBL] [Abstract][Full Text] [Related]
15. Hsp27 and its expression pattern in diffusely infiltrating astrocytomas.
Mäkelä KS; Haapasalo JA; Ilvesaro JM; Parkkila S; Paavonen T; Haapasalo HK
Histol Histopathol; 2014 Sep; 29(9):1161-8. PubMed ID: 24599602
[TBL] [Abstract][Full Text] [Related]
16. Supratentorial World Health Organization Grade 2 astrocytomas and oligoastrocytomas. A new pattern of prognostic factors.
Kreth FW; Faist M; Rossner R; Volk B; Ostertag CB
Cancer; 1997 Jan; 79(2):370-9. PubMed ID: 9010111
[TBL] [Abstract][Full Text] [Related]
17. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
[TBL] [Abstract][Full Text] [Related]
18. Early prognostic factors related to progression and malignant transformation of low-grade gliomas.
Jung TY; Jung S; Moon JH; Kim IY; Moon KS; Jang WY
Clin Neurol Neurosurg; 2011 Nov; 113(9):752-7. PubMed ID: 21889256
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas.
Majumdar K; Radotra BD; Vasishta RK; Pathak A
Surg Neurol; 2009 Jul; 72(1):54-60. PubMed ID: 19559929
[TBL] [Abstract][Full Text] [Related]
20. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
